DK129447B - Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf. - Google Patents

Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.

Info

Publication number
DK129447B
DK129447B DK618668AA DK618668A DK129447B DK 129447 B DK129447 B DK 129447B DK 618668A A DK618668A A DK 618668AA DK 618668 A DK618668 A DK 618668A DK 129447 B DK129447 B DK 129447B
Authority
DK
Denmark
Prior art keywords
alkylaminopropanes
racemic
phenoxy
sec
hydroxy
Prior art date
Application number
DK618668AA
Other languages
English (en)
Other versions
DK129447C (da
Inventor
H Koeppe
W Kummer
H Staehle
K Zeile
W Traunecker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK129447B publication Critical patent/DK129447B/da
Application granted granted Critical
Publication of DK129447C publication Critical patent/DK129447C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK618668AA 1967-12-18 1968-12-17 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf. DK129447B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEB0095902 1967-12-18
DEB0095988 1967-12-22

Publications (2)

Publication Number Publication Date
DK129447B true DK129447B (da) 1974-10-14
DK129447C DK129447C (da) 1975-03-03

Family

ID=25968397

Family Applications (1)

Application Number Title Priority Date Filing Date
DK618668AA DK129447B (da) 1967-12-18 1968-12-17 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.

Country Status (11)

Country Link
US (1) US3644469A (da)
JP (1) JPS5210854B1 (da)
BE (1) BE725679A (da)
CA (1) CA956641A (da)
CH (1) CH512427A (da)
DK (1) DK129447B (da)
ES (8) ES361530A1 (da)
FR (2) FR1595323A (da)
GB (1) GB1260848A (da)
NL (1) NL163775C (da)
SE (1) SE358382B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975539A (en) * 1935-11-15 1976-08-17 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N,N-bis-(3-phenoxy-2-hydroxy-propyl)-alkylenediamine and method of use
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
FR2119843B1 (da) * 1970-12-28 1974-03-22 Laroche Navarro Labo
US4145442A (en) * 1972-04-04 1979-03-20 Aktiebolaget Hassle Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
JPS49245A (da) * 1972-04-17 1974-01-05
ZA741812B (en) * 1973-04-18 1975-04-30 Haessle A New amines and process for their preparation
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
DE2645710C2 (de) * 1976-10-09 1985-06-27 Merck Patent Gmbh, 6100 Darmstadt Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
US4347177A (en) * 1980-04-14 1982-08-31 Burroughs Wellcome Co. Compounds and methods of making them
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
JPS60100961U (ja) * 1983-12-15 1985-07-10 豊根　實 植木鉢
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions
EA003286B1 (ru) * 1999-12-14 2003-04-24 Сова Денко К.К. Способ получения солей цианобензиламинов

Also Published As

Publication number Publication date
ES379736A1 (es) 1973-02-01
BE725679A (da) 1969-06-18
DK129447C (da) 1975-03-03
ES379735A1 (es) 1973-01-16
ES379733A1 (es) 1973-01-16
SE358382B (da) 1973-07-30
ES361530A1 (es) 1970-11-01
FR1595323A (da) 1970-06-08
NL163775B (nl) 1980-05-16
ES379731A1 (es) 1973-01-16
NL6818101A (da) 1969-06-20
FR8262M (da) 1970-10-19
GB1260848A (en) 1972-01-19
ES379738A1 (es) 1973-02-01
NL163775C (nl) 1980-10-15
CH512427A (de) 1971-09-15
CA956641A (en) 1974-10-22
ES379737A1 (es) 1973-02-01
ES379739A1 (es) 1973-02-01
JPS5210854B1 (da) 1977-03-26
US3644469A (en) 1972-02-22

Similar Documents

Publication Publication Date Title
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
DK123022B (da) Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf.
DK120756B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive norscopolaminderivater eller syreadditionssalte eller kvaternære salte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK122133B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK121512B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 5-phenyl-6,7-benzomorphaner eller syreadditionssalte deraf.
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK131935B (da) Analogifremgangsmåde til fremstilling af aminoalkynyllaktamforbindelser eller syreadditionssalte deraf.
DK125639B (da) Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
DK131988B (da) Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 1-aryloxy-2-hydroxy-3-isopropylamino-propaner eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK129699B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 9,10-dihydro-9,10-ethano-anthracener eller syreadditionssalte deraf.
DK130587B (da) Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf.
DK137674B (da) Analogifremgangsmåde til fremstilling af monophenylsubstituerede oxazoler eller syreadditionssalte deraf.
DK126781B (da) Analogifremgangsmåde til fremstilling af pyrrolidinoguanidinforbindelser eller syreadditionssalte deraf.
DK121513B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive N-substituerede noratropiniumsalte.
DK131670B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive alfa-substituerede 2-amino-methyl-benzylalkoholer eller syreadditionssalte heraf.
DK135128B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive estre af alfa-aminobenzylpenicillin.
DK132551B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive carbamoylalkoxyphenoxyisopropanolaminderivater eller syreadditionssalte deraf.
DK128813B (da) Analogifremgangsmåde til fremstilling af basisk substituerede thiophthalaner eller syreadditionssalte deraf.
DK131281B (da) Analogifremgangsmåde til fremstilling af erythro- eller threo-alfa-(1-aminoethyl)-benzylalkohol-3-ethere eller syreadditionssalte heraf eller de tilsvarende optisk aktive forbindelser.
DK128237B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive N-alkyl-substituerede (2-cyano-5-methylphenoxy)-propanolaminer eller fysiologisk acceptable syreadditionssalte deraf.

Legal Events

Date Code Title Description
PBP Patent lapsed